Your institution may have access to this item. Find your institution then sign in to continue.
Title
Market watch.
Abstract
The article discusses recent trends in biotechnology stocks. The Nasdaq Biotechnology Index has declined steadily during the latter part of 2006, but recovered in early January 2007 to its mid-November levels. The downtrend in individual stocks was caused by poor data from clinical trials. Later gains were stimulated by the announcement of licensing and partnership deals.